25th Nov 2013 18:13
LONDON (Alliance News) - Skyepharma PLC Monday said Chief Financial Officer Andrew Derodra was awarded 2,000 potential shares under its long term incentive plan from the company's remuneration committee at GBP1 each.
Derorda joined the company in August from luxury food group Tate & Lyle where he led the finance and control team.
Following this transaction, Derorda now holds 200,000 shares.
The stock closed at 117.84 pence Monday, down 1.66 pence or 1.4%.
By Anthony Tshibangu; [email protected];
Copyright © 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
SKP.L